ID   IPMK_RAT                Reviewed;         396 AA.
AC   Q99NI4;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   24-JUL-2024, entry version 128.
DE   RecName: Full=Inositol polyphosphate multikinase {ECO:0000303|PubMed:11226235};
DE            EC=2.7.1.140 {ECO:0000269|PubMed:15528195};
DE            EC=2.7.1.151 {ECO:0000269|PubMed:11226235, ECO:0000269|PubMed:15528195};
DE            EC=2.7.1.153 {ECO:0000269|PubMed:16123124};
DE   AltName: Full=Inositol 1,3,4,6-tetrakisphosphate 5-kinase;
GN   Name=Ipmk; Synonyms=Impk, Ipk2 {ECO:0000303|PubMed:15528195};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, COFACTOR, PATHWAY, TISSUE
RP   SPECIFICITY, AND CATALYTIC ACTIVITY.
RX   PubMed=11226235; DOI=10.1073/pnas.041614598;
RA   Saiardi A., Nagata E., Luo H.R., Sawa A., Luo X., Snowman A.M.,
RA   Snyder S.H.;
RT   "Mammalian inositol polyphosphate multikinase synthesizes inositol 1,4,5-
RT   trisphosphate and an inositol pyrophosphate.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:2306-2311(2001).
RN   [2]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, FUNCTION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=16123124; DOI=10.1073/pnas.0506184102;
RA   Resnick A.C., Snowman A.M., Kang B.N., Hurt K.J., Snyder S.H., Saiardi A.;
RT   "Inositol polyphosphate multikinase is a nuclear PI3-kinase with
RT   transcriptional regulatory activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:12783-12788(2005).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, AND MUTAGENESIS OF
RP   ASP-127.
RX   PubMed=15528195; DOI=10.1074/jbc.m412006200;
RA   Fujii M., York J.D.;
RT   "A role for rat inositol polyphosphate kinases, rIpk2 and rIpk1, in
RT   inositol pentakisphosphate and inositol hexakisphosphate production in Rat-
RT   1 cells.";
RL   J. Biol. Chem. 280:1156-1164(2005).
CC   -!- FUNCTION: Inositol phosphate kinase with a broad substrate specificity.
CC       Phosphorylates inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) first to
CC       inositol 1,3,4,5-tetrakisphosphate and then to inositol 1,3,4,5,6-
CC       pentakisphosphate (Ins(1,3,4,5,6)P5) (PubMed:11226235,
CC       PubMed:15528195). Phosphorylates inositol 1,3,4,6-tetrakisphosphate
CC       (Ins(1,3,4,6)P4) (PubMed:15528195). Phosphorylates inositol 1,4,5,6-
CC       tetrakisphosphate (Ins(1,4,5,6)P4) (PubMed:15528195). Phosphorylates
CC       glycero-3-phospho-1D-myo-inositol 4,5-bisphosphate to glycero-3-
CC       phospho-1D-myo-inositol 3,4,5-trisphosphate (PubMed:16123124). Plays an
CC       important role in MLKL-mediated necroptosis via its role in the
CC       biosynthesis of inositol pentakisphosphate (InsP5) and inositol
CC       hexakisphosphate (InsP6). Binding of these highly phosphorylated
CC       inositol phosphates to MLKL mediates the release of an N-terminal auto-
CC       inhibitory region, leading to activation of the kinase. Essential for
CC       activated phospho-MLKL to oligomerize and localize to the cell membrane
CC       during necroptosis (By similarity). Required for normal embryonic
CC       development, probably via its role in the biosynthesis of inositol
CC       1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P5) and inositol
CC       hexakisphosphate (InsP6) (By similarity).
CC       {ECO:0000250|UniProtKB:Q7TT16, ECO:0000250|UniProtKB:Q8NFU5,
CC       ECO:0000269|PubMed:11226235, ECO:0000269|PubMed:15528195,
CC       ECO:0000269|PubMed:16123124}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 1,4,5-trisphosphate + 2 ATP = 1D-myo-inositol
CC         1,3,4,5,6-pentakisphosphate + 2 ADP + 2 H(+); Xref=Rhea:RHEA:32359,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:57733,
CC         ChEBI:CHEBI:203600, ChEBI:CHEBI:456216; EC=2.7.1.151;
CC         Evidence={ECO:0000269|PubMed:11226235, ECO:0000269|PubMed:15528195};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 1,3,4,6-tetrakisphosphate + ATP = 1D-myo-
CC         inositol 1,3,4,5,6-pentakisphosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:12717, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57660, ChEBI:CHEBI:57733, ChEBI:CHEBI:456216;
CC         EC=2.7.1.140; Evidence={ECO:0000269|PubMed:15528195};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-2-(5Z,8Z,11Z,14Z)-eicosatetraenoyl-sn-glycero-
CC         3-phospho-1D-myo-inositol 4,5-bisphosphate + ATP = 1-octadecanoyl-2-
CC         (5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho-(1D-myo-
CC         inositol 3,4,5-triphosphate) + ADP + H(+); Xref=Rhea:RHEA:43396,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:77137,
CC         ChEBI:CHEBI:83243, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000250|UniProtKB:Q8NFU5};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) + ATP = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
CC         inositol-3,4,5-trisphosphate) + ADP + H(+); Xref=Rhea:RHEA:21292,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:57836,
CC         ChEBI:CHEBI:58456, ChEBI:CHEBI:456216; EC=2.7.1.153;
CC         Evidence={ECO:0000269|PubMed:16123124};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21293;
CC         Evidence={ECO:0000305|PubMed:16123124};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1D-myo-inositol 1,4,5,6-tetrakisphosphate + ATP = 1D-myo-
CC         inositol 1,3,4,5,6-pentakisphosphate + ADP + H(+);
CC         Xref=Rhea:RHEA:11856, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57627, ChEBI:CHEBI:57733, ChEBI:CHEBI:456216;
CC         Evidence={ECO:0000269|PubMed:15528195};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000305|PubMed:11226235};
CC       Note=Binds two Mg(2+), but the interaction with the protein is mostly
CC       indirect. {ECO:0000250|UniProtKB:Q8NFU5};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=6 uM for 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-
CC         bisphosphate) {ECO:0000269|PubMed:16123124};
CC         Vmax=0.7 umol/min/mg enzyme for 1,2-diacyl-sn-glycero-3-phospho-(1D-
CC         myo-inositol-4,5-bisphosphate) {ECO:0000269|PubMed:16123124};
CC   -!- PATHWAY: Phospholipid metabolism; phosphatidylinositol metabolism.
CC       {ECO:0000269|PubMed:11226235}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15528195,
CC       ECO:0000269|PubMed:16123124}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in kidney, and at lower levels in
CC       hippocampus, brain cortex, cerebellum, heart and lung.
CC       {ECO:0000269|PubMed:11226235}.
CC   -!- SIMILARITY: Belongs to the inositol phosphokinase (IPK) family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY014898; AAG42923.1; -; mRNA.
DR   RefSeq; NP_599244.1; NM_134417.1.
DR   AlphaFoldDB; Q99NI4; -.
DR   SMR; Q99NI4; -.
DR   STRING; 10116.ENSRNOP00000000748; -.
DR   SwissLipids; SLP:000000959; -.
DR   iPTMnet; Q99NI4; -.
DR   PhosphoSitePlus; Q99NI4; -.
DR   PaxDb; 10116-ENSRNOP00000000748; -.
DR   GeneID; 171458; -.
DR   KEGG; rno:171458; -.
DR   UCSC; RGD:620954; rat.
DR   AGR; RGD:620954; -.
DR   CTD; 253430; -.
DR   RGD; 620954; Ipmk.
DR   VEuPathDB; HostDB:ENSRNOG00000000609; -.
DR   eggNOG; KOG1620; Eukaryota.
DR   HOGENOM; CLU_042569_0_0_1; -.
DR   InParanoid; Q99NI4; -.
DR   OrthoDB; 20180at2759; -.
DR   PhylomeDB; Q99NI4; -.
DR   TreeFam; TF321442; -.
DR   BRENDA; 2.7.1.151; 5301.
DR   Reactome; R-RNO-1855191; Synthesis of IPs in the nucleus.
DR   SABIO-RK; Q99NI4; -.
DR   UniPathway; UPA00949; -.
DR   PRO; PR:Q99NI4; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000000609; Expressed in kidney and 20 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0046934; F:1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0097243; F:flavonoid binding; ISO:RGD.
DR   GO; GO:0000824; F:inositol tetrakisphosphate 3-kinase activity; IDA:UniProtKB.
DR   GO; GO:0047326; F:inositol tetrakisphosphate 5-kinase activity; IDA:UniProtKB.
DR   GO; GO:0000825; F:inositol tetrakisphosphate 6-kinase activity; IDA:UniProtKB.
DR   GO; GO:0051765; F:inositol tetrakisphosphate kinase activity; IBA:GO_Central.
DR   GO; GO:0008440; F:inositol-1,4,5-trisphosphate 3-kinase activity; ISO:RGD.
DR   GO; GO:0000823; F:inositol-1,4,5-trisphosphate 6-kinase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0102732; F:myo-inositol-1,2,3,4,6-heptakisphosphate 5-kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0032958; P:inositol phosphate biosynthetic process; ISO:RGD.
DR   GO; GO:0032957; P:inositol trisphosphate metabolic process; ISO:RGD.
DR   GO; GO:0070266; P:necroptotic process; ISS:UniProtKB.
DR   GO; GO:0001841; P:neural tube formation; ISO:RGD.
DR   GO; GO:0046488; P:phosphatidylinositol metabolic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.30.470.160; Inositol polyphosphate kinase; 1.
DR   InterPro; IPR005522; IPK.
DR   InterPro; IPR038286; IPK_sf.
DR   PANTHER; PTHR12400; INOSITOL POLYPHOSPHATE KINASE; 1.
DR   PANTHER; PTHR12400:SF51; INOSITOL POLYPHOSPHATE MULTIKINASE; 1.
DR   Pfam; PF03770; IPK; 1.
DR   SUPFAM; SSF56104; SAICAR synthase-like; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Kinase; Lipid metabolism; Magnesium;
KW   Metal-binding; Nucleotide-binding; Nucleus; Phospholipid metabolism;
KW   Phosphoprotein; Reference proteome; Transferase.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   CHAIN           2..396
FT                   /note="Inositol polyphosphate multikinase"
FT                   /id="PRO_0000066872"
FT   REGION          1..22
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           300..310
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         58
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         65
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         114..116
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         127
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         129
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         143..150
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         179
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   BINDING         365
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8NFU5"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q7TT16"
FT   MUTAGEN         127
FT                   /note="D->A: Shows weak but significant activity toward the
FT                   substrate 1D-myo-inositol 1,4,5-trisphosphate."
FT                   /evidence="ECO:0000269|PubMed:15528195"
SQ   SEQUENCE   396 AA;  44410 MW;  781BF569245FFA02 CRC64;
     MAAEPPALRL RPPGSTGDSP PVPRLLGGCV PLSHQVAGHM YGKDKVGILQ HPDGTVLKQL
     QPPPRGPREL EFYTMVYAAD CADAVLLELR KHLPKYYGVW SPPSAPNDVY LKLEDVTHKF
     NKPCIMDVKI GRKSYDPFAS AEKIQQQVSK YPLMEEIGFL VLGMRVYHLH SDSYETQNQH
     YGRGLTKETL KEGVSKFFHN GFCLRKDAVA ASIQKVEKIL QWFENQKQLN FYASSLLFVY
     EGSSQPATTK SNDRTLAGRF LSKGALSDAD VLECNNNFHL FSSPANGTSV GKSLSKAYSR
     HRKLYAKKHQ SQTSLKVETL EQDNGWKSMS QEHLNGNVLS QLEKVFYHLP AGRQEIAEAE
     VRMIDFAHVF PSNTVDEGYV YGLKHLIAVL RSILDS
//
